Functional dissection of the pro-apoptotic protein Bik - Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death

被引:57
作者
Elangovan, B [1 ]
Chinnadurai, G [1 ]
机构
[1] ST LOUIS UNIV,MED CTR,INST MOL VIROL,ST LOUIS,MO 63110
关键词
D O I
10.1074/jbc.272.39.24494
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bik is a potent pro-apoptotic protein, which complexes with various anti-apoptotic proteins such as Bcl-2, Bcl-x(L), 19-kDa adenovirus E1B, and EBV-BHRF1, The mechanism by which Bik promotes cell death is not known, It shares a conserved domain, BH3, with other pro-apoptotic proteins, Bar, Bah, Bid, and Hrk, and certain anti-apoptosis proteins such as Bcl-2 and Bcl-x(L). Mutations within the BH3 domain of Bik abrogate its ability to induce cell death and to complex with anti-apoptosis proteins, This result is consistent with the hypothesis that Bik may promote cell death by complexing with and antagonizing the activity of endogenous cellular anti-apoptosis proteins such as Bcl-2 and Bcl-x(L). To elucidate the relationship between protein complex formation and induction of cell death, we have identified the minimal sequences of Bik, from a library of N-terminal and C-terminal deletion mutants, required for interaction with Bcl-2 and Bcl-x, and for inducing efficient cell death, Two-hybrid analysis ill yeast and immunoprecipitation analysis of proteins expressed in mammalian cells indicate that a 52-amino acid region (amino acids 43-94) of Bik, encompassing the BH3 domain, is sufficient for efficient heterodimerization with Bcl-2 and Bcl-x(L) Protein interaction studies further reveal that an 18-amino acid region, encompassing the BH3 domain (residues 57-74), constitutes the core heterodimerization domain. Functional analysis indicates that a Bik deletion mutant expressing residues 43-120, which efficiently heterodimerizes with the anti-apoptosis proteins Bcl-2 and Bel-x(L), is defective in eliciting cell death. In contrast, a mutant expressing additional C-terminal sequences (amino acids 43-134) interacts with the survival proteins and elicits efficient cell death. Our results suggest that for Bik-mediated cell death, the heterodimerization activity encoded by the BH3 domain alone is insufficient and raise the possibility-that Bik may induce cell death autonomous of heterodimerization with survival proteins such as Bcl-2 and Bcl-x(L).
引用
收藏
页码:24494 / 24498
页数:5
相关论文
共 24 条
[21]   BID: A novel BH3 domain-only death agonist [J].
Wang, K ;
Yin, XM ;
Chao, DT ;
Milliman, CL ;
Korsmeyer, SJ .
GENES & DEVELOPMENT, 1996, 10 (22) :2859-2869
[22]   STRUCTURE AND MECHANISM OF INTERLEUKIN-1-BETA CONVERTING-ENZYME [J].
WILSON, KP ;
BLACK, JAF ;
THOMSON, JA ;
KIM, EE ;
GRIFFITH, JP ;
NAVIA, MA ;
MURCKO, MA ;
CHAMBERS, SP ;
ALDAPE, RA ;
RAYBUCK, SA ;
LIVINGSTON, DJ .
NATURE, 1994, 370 (6487) :270-275
[23]   BH1 AND BH2 DOMAINS OF BCL-2 ARE REQUIRED FOR INHIBITION OF APOPTOSIS AND HETERODIMERIZATION WITH BAX [J].
YIN, XM ;
OLTVAI, ZN ;
KORSMEYER, SJ .
NATURE, 1994, 369 (6478) :321-323
[24]   Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BN3) distinct from BH1 and BH2 [J].
Zha, HB ;
AimeSempe, C ;
Sato, T ;
Reed, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7440-7444